Search research articles
Contact Us
Filters
Showing results (51-60 of 183) with videos related to
Page
of 19
Sort By:
American Journal of Clinical Oncology
|
January 1, 1991
Cytokines in tumor therapy. Interleukin-3
R Kurzrock, Z Estrov, M Talpaz, et al.
Blood Cells
|
January 1, 1986
Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines
C Kaplinsky, Z Estrov, M H Freedman, et al.
Annals of Internal Medicine
|
July 31, 1999
Chronic myelogenous leukemia: biology and therapy
S Faderl, M Talpaz, Z Estrov, et al.
Blood
|
April 27, 1999
Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?
S Faderl, M Talpaz, H M Kantarjian, et al.
Experimental Hematology
|
September 1, 1995
Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation
Z Estrov, M Talpaz, E H Estey, et al.
The American Journal of Pediatric Hematology/Oncology
|
January 1, 1988
Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity
Z Estrov, A Cohen, E W Gelfand, et al.
Leukemia
|
March 31, 1998
DNA in situ hybridization of individual colonies to determine lineage derivation in leukemia
R Kurzrock, M Talpaz, M Beran, et al.
The Journal of Pediatric Endocrinology
|
January 1, 1993
The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission--a preliminary report
Z Zadik, Z Estrov, Y Karov, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Dosing of thioTEPA for myeloablative therapy
D Przepiorka, T Madden, C Ippoliti, et al.
Blood
|
May 1, 1986
Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures
Z Estrov, T Grunberger, H S Chan, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 183) with videos related to
Sort By:
Page
of 19
American Journal of Clinical Oncology
|
January 1, 1991
Cytokines in tumor therapy. Interleukin-3
R Kurzrock, Z Estrov, M Talpaz, et al.
Blood Cells
|
January 1, 1986
Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines
C Kaplinsky, Z Estrov, M H Freedman, et al.
Annals of Internal Medicine
|
July 31, 1999
Chronic myelogenous leukemia: biology and therapy
S Faderl, M Talpaz, Z Estrov, et al.
Blood
|
April 27, 1999
Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?
S Faderl, M Talpaz, H M Kantarjian, et al.
Experimental Hematology
|
September 1, 1995
Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation
Z Estrov, M Talpaz, E H Estey, et al.
The American Journal of Pediatric Hematology/Oncology
|
January 1, 1988
Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity
Z Estrov, A Cohen, E W Gelfand, et al.
Leukemia
|
March 31, 1998
DNA in situ hybridization of individual colonies to determine lineage derivation in leukemia
R Kurzrock, M Talpaz, M Beran, et al.
The Journal of Pediatric Endocrinology
|
January 1, 1993
The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission--a preliminary report
Z Zadik, Z Estrov, Y Karov, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Dosing of thioTEPA for myeloablative therapy
D Przepiorka, T Madden, C Ippoliti, et al.
Blood
|
May 1, 1986
Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures
Z Estrov, T Grunberger, H S Chan, et al.
Page
of 19